OnKure Therapeutics, Inc.
OKUR
$2.60
-$0.02-0.76%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -3.37% | -6.95% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.04% | -3.98% | |||
| Operating Income | 5.04% | 3.98% | |||
| Income Before Tax | 4.49% | 3.36% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 4.49% | 3.36% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 4.49% | 3.36% | |||
| EBIT | 5.04% | 3.98% | |||
| EBITDA | 5.02% | 4.00% | |||
| EPS Basic | 4.64% | 3.97% | |||
| Normalized Basic EPS | 4.63% | 3.97% | |||
| EPS Diluted | 4.64% | 3.97% | |||
| Normalized Diluted EPS | 4.63% | 3.97% | |||
| Average Basic Shares Outstanding | 0.16% | 0.63% | |||
| Average Diluted Shares Outstanding | 0.16% | 0.63% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||